SNDY News Alert Solos Endoscopy Inc (SNDY) 0.0005 09/28/2014

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Solos Endoscopy Inc (SNDY) 0.0005 $SNDY

Solos Endoscopy Files for Medical Device License to Distribute its Endoscopic Instruments in Canada
ACCESSWIRE - Tue Sep 16, 9:42AM CDT
BOSTON, MA / ACCESSWIRE / September 16, 2014 / Solos Endoscopy, Inc. (OTC PINK: SNDY) (PINKSHEETS: SNDY), a provider of quality innovative healthcare instruments to hospitals across the United States, is pleased to announce that the company has completed its filing for the Canadian Medical Device License, which will allow Solos to sell certain endoscopic instruments, including the MammoView(R) devices, in Canada.

Solos Endoscopy Reports Financial Results for Period Ended June 30, 2014
ACCESSWIRE - Mon Aug 18, 11:00AM CDT
BOSTON, MA / ACCESSWIRE / August 18, 2014 / Solos Endoscopy, Inc. (OTC Pink: SNDY) (PINKSHEETS: SNDY) a provider of quality innovative healthcare instruments to Hospitals across the United States, reported sales and earnings results for period ended June 30, 2014, and its quarterly disclosure statement on OTC Markets.com.

Solos Endoscopy Posts Shareholder Update on OTC Markets.com
ACCESSWIRE - Wed Jul 23, 9:23AM CDT
BOSTON, MA / ACCESSWIRE / July 23, 2014 / Solos Endoscopy, Inc. (OTC Pink: SNDY) a provider of quality innovative healthcare instruments to Hospitals across the Country, posted an update for the shareholders on OTC Markets.com.

Solos Endoscopy Reports Financial Results for Period Ended December 31, 2013
Marketwire - Tue Apr 01, 9:05AM CDT
Solos Endoscopy, Inc. (OTC Pink: SNDY) (PINKSHEETS: SNDY), a provider of quality innovative healthcare instruments to hospitals across the United States, reported sales and earnings results for the period ended December 31, 2013.

Solos Endoscopy to Begin Distribution of Its Endoscopic Instruments in Canada
Marketwire - Thu Feb 20, 10:41AM CST
Solos Endoscopy, Inc. (OTC Pink: SNDY), a provider of quality innovative healthcare instruments to hospitals across the United States, is pleased to announce that the company has commenced negotiations with a Canadian distributor to sell its endoscopic instruments including the MammoView(R) devices in Canada.

Halozyme Announces Positive Opinion From CHMP For European Approval Of Roche's MabThera SC
PR Newswire - Fri Jan 24, 10:32AM CST
Halozyme Therapeutics, Inc. (NASDAQ: HALO) announced today that the EU Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission approve Roche's subcutaneous (SC) formulation of MabThera® (rituximab) using Halozyme's recombinant human hyaluronidase (rHuPH20) for the treatment of patients with common forms of non-Hodgkin lymphoma (NHL).

Pain Therapeutics - Drugs, Markets and Companies
PR Newswire - Thu Jan 16, 1:00PM CST
Dublin - Research and Markets (http://www.researchandmarkets.com/research/sqmftt/pain_therapeutics) has announced the addition of a new report "Pain Therapeutics - Drugs, Markets and Companies" to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 )

Solos Endoscopy Completes Stage 2 of its ISO 13485 Audit with TUV SUD America
ACCESSWIRE - Thu Aug 22, 8:06AM CDT
BOSTON, MA, August 22, 2013 - (Accesswire) - Solos Endoscopy, Inc. (OTCPink: SNDY) is pleased to announce that TUV SUD America has completed its Stage 2 ISO 13485 Audit with Solos Endoscopy on August 16, 2013. Solos Endoscopy will be certified to ISO 13485:2003, the internationally-recognized standard for quality systems for medical device manufacturers, once it reviews and resolves any corrective actions that were discovered during the final audit.

Solos Endoscopy Reports 2nd Quarter Results
ACCESSWIRE - Wed Aug 14, 11:15AM CDT
Company Posts Financials for Period Ended June 30, 2013, President's Letter to Shareholders

Solos Endoscopy Retains Emergo Group to be the Authorized Representative for the Importation of Solos Instruments into Europe
ACCESSWIRE - Fri Aug 02, 8:06AM CDT
BOSTON, August 2, 2013 - Solos Endoscopy, Inc. (OTC PINK: SNDY) is pleased to announce that the Company has retained Emergo Group to act as the Company's authorized representative in Europe. Emergo Group will provide Solos assistance related to communications with authorities and importation of Solos instruments into Europe.

Solos Endoscopy's MammoView(R) System Offers Women Early Breast Cancer Detection
ACCESSWIRE - Thu Jul 18, 12:01PM CDT
BOSTON, MA, July 18, 2013 - (eTeligis via ACCESSWIRE) - Solos Endoscopy, Inc. (OTC PINK: SNDY) is pleased to announce that the Company's MammoView(R) Breast Endoscopy System can aid in giving women the best prognosis for recovery by detecting breast cancer at an earlier stage than conventional methods (http://www.solosendoscopy.com/ductoscope-sell-sheet-final.pdf).

Solos Endoscopy and TUV SUD America Schedule Stage 2 ISO 13485 Audit for August 16, 2013
PR Newswire - Wed Jun 12, 9:06AM CDT
Solos Endoscopy, Inc. (OTCPK: SNDY) is pleased to announce that the Company and TUV SUD America has scheduled its Stage 2 ISO 13485 Audit for August 16, 2013.

Solos Endoscopy Reports Full Year 2012 Results
PR Newswire - Wed May 15, 8:36AM CDT
Solos Endoscopy, Inc. (OTCPK: SNDY), a provider of quality innovative healthcare instruments to Hospitals across the Country, reported sales and earnings results for the full year ended December 31, 2012.

Solos Endoscopy Management Announces Goals for 2013
PR Newswire - Fri Jan 04, 9:16AM CST
Solos Endoscopy, Inc. (OTCPK: SNDY) is pleased to announce that the Company plans to continue its progress in 2013 as its management has announced its goals for moving forward in the New Year.




Scroll down for more posts ▼

Top 10 Most Recent News Articles

HSBC Boosts Tender Offer: Capital Management Maneuver

Updated Category News Views 56

HSBC Raises Stake in Its Own Game See folks, when HSBC announces it's bumping up the ceiling on buying back its own securities, you know there's a game afoot in the capital management arena. They raised the offering to snag up these $3 billion 6% perpetuals from $1 billion up to a hefty $1.5 billion. It's like they’re saying, 'Hey, let’s tighten the belt and make sure...

Continue Reading
SAS: A Leader in AML Transaction Monitoring Tech

Updated Category News Views 90

The Evolving Landscape of AML Solutions Banks are drowning in a sea of alerts these days, making it tough to sift through and identify real threats. In this wild scenario, SAS has snagged the spotlight, with Chartis Research tipping its hat to them again. Their Anti-Money Laundering (AML) technology is planted right at the cutting edge of this rapidly changing landscape....

Continue Reading
Aries Ignites a Social Renaissance in La Jolla

Updated Category News Views 83

The Dawn of Aries: A Beacon for Social Change Coming out of nowhere, Aries is set to make waves in La Jolla, and no, I'm not talking about another swell hitting the shores. Instead, we're witnessing a new chapter for the rooftop of Hotel La Jolla, where an investment of over a cool million bucks aims to deliver a slice of European flare right here on the Pacific. A...

Continue Reading
iQIYI's AI Resurrects 90-Year-Old Lost Film

Updated Category News Views 24

A Nod to the Past with Tech of Tomorrow Diving into the nitty-gritty of iQIYI's latest cinematic triumph, there's a world where film meets futuristic AI, turning a motley crew of photos and clippings into a full-fledged movie. It's sorcery, if you ask me. "Visiting Shanghai after Sixty Years", vanished for nearly 90 years, has been crafted into existence again by...

Continue Reading
AutoFull Drops C3 Pro—Gaming Chairs With Flair

Updated Category News Views 63

AutoFull Gambles on Flair and Comfort AutoFull is shaking things up with the C3 Pro Series, blending striking aesthetics and tech-focused comfort features aimed right at gamers' sweet spots. Launching ahead of the Black Friday buzz, these new models promise to add some serious pizzazz to your gaming setup, whether it's the Advanced model's extra features or the more basic...

Continue Reading
Major Donations Boost Mesothelioma Research Funding

Updated Category News Views 104

Significant Boosts in Mesothelioma Support November's chill didn't slow down major support for mesothelioma initiatives. On October 22, 2026, during the grand setting of the Foundation's 2026 International Symposium on Malignant Mesothelioma in The Woodlands, Texas, MesoCare.org and Danziger & De Llano, LLP stepped up big time. Their philanthropic moves weren't just about...

Continue Reading
Kuaishou Prepares for Q3 Financial Reveals—November 19

Updated Category News Views 53

We're watching the countdown to November 19, 2026, when Kuaishou Technology plans to spill the beans on its third-quarter earnings. Now, the clock's ticking not just in Beijing but across the financial landscape, as investors everywhere hold their breaths, hoping for some juicy financial insights from this colossal social platform. It's a heavyweight showdown any stock...

Continue Reading
AiNET Prevails in Breach of Contract Jury Verdict

Updated Category News Views 44

AiNET's Legal Triumph Shakes Up the IT Sector Well, talk about a courtroom drama. Greenberg Traurig just snagged a big win for AiNET over in Prince George's County, Maryland, and it's a classic reminder that due diligence isn't just a nice-to-have—it's a must. AiNET found itself in the center of a breach of contract brawl with Tech Finance Co., and guess what? The jury...

Continue Reading
Custom Antibody Market Eyes $1.13B by 2031 Growth

Updated Category News Views 152

Examining the Custom Antibody Market's Growth Projections The custom antibody market's been reeling in some serious attention lately. With the muscle to hit $1.13 billion by the end of 2031, this market's not slouching around. We're talking about a 9.5% compound annual growth rate here, folks. Now that's a figure that gives you something to chew over your coffee. What...

Continue Reading
Alley Cat Allies Sues Lincolnton Over Cat Shooting

Updated Category News Views 9

Legal Battle Over a Cat's Tragic End Picture the scene: a peaceful neighborhood in Lincolnton, Georgia, where the serenity was ripped apart by the shocking shooting of Piper the cat. This isn't some playground scuffle, my friends. Alley Cat Allies has taken this tragedy to the courts, filing a lawsuit against the city and its mayor. What's at stake here isn't just legal...

Continue Reading

Top 5 Most Recently Viewed Articles

The Future of Lead Acid Batteries: Market Trends and Insights

Updated Category News Views 319

Significant Growth Expected in the Lead Acid Battery Market The global lead acid battery market is poised for substantial growth, with revenue expected to surge from US$ 51.93 billion to US$ 91.76 billion in the coming years. This growth trajectory showcases a robust CAGR of 6.53%, illustrating the market's resilience and adaptability in the face of evolving consumer...

Continue Reading
Bullish Investors Eye Exact Sciences: Insights on EXAS Options

Updated Category News Views 78

Investor Interest in Exact Sciences Options Investors with significant capital are becoming increasingly optimistic about Exact Sciences Corporation (NASDAQ: EXAS). This trend is important for anyone involved in the market to pay attention to. Recent observations have pointed to a notable shift in the options market, suggesting that something significant could be...

Continue Reading
MCAP Inc. Declares Exciting New Dividend for Shareholders

Updated Category News Views 241

MCAP Inc. Declares $0.10 Dividend Per Share MCAP Inc. (OTC: MCAP) has made an exciting announcement regarding dividend payouts to its shareholders. The Board of Directors has approved a $0.10 dividend per common share. This dividend reflects the company's commitment to returning value to its shareholders. Details of the Dividend Announcement The announced dividend will be...

Continue Reading
Trua's Stuart Vaeth to Address Trust in Gig Economy at Curbivore

Updated Category News Views 323

Trua's Insights on Trust and Safety in the Gig Economy Stuart Vaeth, the Senior Vice President of Strategic Business Development at Trua, a leader in digital trust technologies, will take center stage at Curbivore, an influential event exploring the landscapes of technology, mobility, and commerce. His participation underscores the need for robust safety measures in the...

Continue Reading
Legal Action for Investors: Class Action Against Applied Therapeutics

Updated Category News Views 132

Understanding the Recent Class Action Lawsuit Against Applied Therapeutics Investor alert: A significant class action lawsuit has emerged against Applied Therapeutics, Inc., a biopharmaceutical company engaged in research and development. This legal action follows claims about misleading statements regarding the company's New Drug Application for their product,...

Continue Reading